G. Leopold

发表

Balanced Pharmacokinetics and Metabolism of Bisoprolol

G. Leopold, 1985, Journal of cardiovascular pharmacology.

Role of volunteer selection in human pharmacology studies

G. Leopold, J. Pabst, W. Ungethüm, 1980 .

Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes

G. Leopold, H. Diekmann, D. Wegner, 1978, European Journal of Clinical Pharmacology.

Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.

H. Wiemann, G. Leopold, K. Bühring, 1986, British journal of clinical pharmacology.

Pharmacokinetics of Bisoprolol During Repeated Oral Administration to Healthy Volunteers and Patients with Kidney or Liver Disease

W. Kirch, G. Leopold, E. Ohnhaus, 1987, Clinical pharmacokinetics.

Pharmacokinetics and Metabolism of Bisoprolol-14C in Three Animal Species and in Humans

G. Leopold, A. Garbe, K. Bühring, 1985, Journal of cardiovascular pharmacology.

Concentration Kinetics of Propranolol, Bisoprolol, and Atenolol in Humans Assessed with Chemical Detection and a Subtype‐Selective &bgr;‐Adrenoceptor Assay

A. Wellstein, G. Belz, D. Palm, 1985, Journal of cardiovascular pharmacology.

Bisoprolol in Angina Pectoris

G. Leopold, H. Bethge, G. Wagner, 1991 .

Placebo controlled comparison of acute effects of ebastine and clemastine on performance and EEG

H. Wiemann, G. Leopold, G. Meuret, 2004, European Journal of Clinical Pharmacology.

Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. III. Investigations of the mechanism of renal elimination.

E. Dingeldein, G. Leopold, J. Pabst, 1979, Arzneimittel-Forschung.

Species differences in influence of divalent cations and of ouabain on ATPase activity on intestinal brush borders of rat and guinea pig.

W. Forth, W. Rummel, G. Leopold, 1971, Biochemical pharmacology.